Upgrade to SI Premium - Free Trial

Northland Capital Remains Positive on Edwards Lifesciences (EW) Long-Term Outlook

February 2, 2017 12:50 PM
Northland Capital Markets analyst Suraj Kalia is sticking with her Outperform rating and $105 price target on Edwards Lifesciences (NYSE ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View

Next Articles